The following is a news release from Novo. Read the full release at novonordisk.com Bagsværd, Denmark, 02 October 2026 – Novo Nordisk today announced that
While suicide has dropped from being the tenth leading cause of death in the United States to the eleventh, it remains the second leading cause
When the subcutaneous injectable medication Hemlibra first hit the market in 2017 it was heralded as a game changer for the hemophilia A community. Now
By Adam Alver, Policy Director Medicaid Work Reporting Requirements Are Here Major changes to Medicaid are already reaching patients in several states. Beginning no later
For more than 50 years a small team at the Centers for Disease Control and Prevention has helped protect Americans living with hemophilia and other
Hemophilia patients are generally satisfied with their treatment but are more than willing to try something better. That’s the consensus from a recent survey by
English 
Español de Puerto Rico